InspireMD (NSPR) Reports In-Line Q2 EPS

InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley upgrades CDW on stronger AI-driven server demand